Pharma and Healthcare Insights & Analytics


Business Description Products/Services

Global Pharma Services Business

Contract Development and Manufacturing
Organisation (CDMO) offering end-to-end
solutions across the drug life cycle through
a globally integrated network of facilities

Read More
  • Discovery Services
  • Process R&D
  • Pharmaceutical Development Services
  • Clinical Trial Supply Services
  • High Potency API Development & Manufacturing
  • API Manufacturing
  • Finished Dosage
    Manufacturing (Oral Solids, Sterile Injectables)
  • Antibody Drug Conjugates

Global Pharma Products Business

A strong product portfolio of niche
differentiated branded generic products
that are difficult to manufacture, sell or

Read More

Inhalation Anaesthetics

  • Sevoflurane
  • Isoflurane
  • Halothane

Injectable Anaesthesia /
Pain Management

  • Sublimaze®
  • Sufenta®
  • Rapifen®
  • Dipidolor®
  • Hypnomidate®

Intrathecal Severe Spasticity /
Pain Management

  • Gablofen®

Injectable for Myxodema Coma

  • Levothyroxine sodium

Capsule for type I Gaucher & Niemann-Pick disease:

  • Miglustat


  • API Generics
  • Vitamins & Premixes

India Consumer Products Business

It caters to the Indian self-care market.
Today, PEL’s OTC range comprises 18
major brands from the pharmaceutical
and personal care space, in diverse
product categories like Vitamins &
Nutrition, Dermatological & Antacids,
Analgesics and Baby Care

Read More

Brands among India’s top OTC brands

  • Saridon
  • Lacto Calamine
  • i-pill
  • Tetmosol
  • Polycrol
  • Naturolax
  • Caladrylh
  • Little’s

Presence in Segments

  • Skin care
  • Pain management
  • Oral care
  • Respiratory
  • Gastro-intestinal
  • Women’s health
  • Baby care and kids wellbeing


  • Successfully completed 2 USFDA inspections, 42 other regulatory inspections and 163 customer
    audits during FY2019
  • Integrated model of services spanning across the entire drug life-cycle
  • Over 70 integrated projects completed till date; 28 integrated projects in FY2019
  • 13 manufacturing facilities across North America, Europe and Asia
  • Built strong capabilities in High Potency APIs and Antibody Drug Conjugates
  • Built niche capabilities in injectable anesthesia, inhalation anesthesia, intrathecal spasticity
    and pain management
  • Integration of key acquired products from Janssen on track
  • Launched Sevoflurane Integrated Closure variant in select European countries
  • Launched MITGO in the US and Miglustat in select European markets
  • Added a few brands in the Vitamins, Minerals, and Nutrients category
  • E-commerce channel was established in FY2019
  • Increasingly using technology and analytics for making decisions in sales and operations
  • Direct reach to ~4.2 lakh outlets with chemist coverage comparable to top OTC players
  • Large field force of around 2,000 people
  • Asset-light model

`4,786 Crores


Pharma Revenues (` Crores)

Note: Pharma includes Global Pharma and India Consumer Products

Global Pharma EBITDA Margins (%)


Business Description Products/Services

Healthcare Insights and Analytics

The Healthcare Insights and Analytics business is a premier
provider of healthcare analytics, data and insight products
and services offering datadriven decision-making resources
and workflow solutions to the world’s leading pharma,
biotech and medical technology companies.

The Company’s best-in-class methodology, talent and
technology enables customers to make informed business
decisions around their most critical commercial challenges.

Read More

Offerings include

  • Research & Data
  • Custom Analytics
  • Consulting & Managed Services

Segments Covered

  • Pharma
  • Medtech
  • Payer and Provider


  • Assisting clients in Pharma, MedTech, Payer, and Provider sectors, addressing some of the most pressing commercial questions facing the healthcare industry
  • Margins to improve through strengthening of India presence, with over 400 employees operating out of India
  • Addressable market size in excess of $16 Billion
  • 100 terabyte, cloud-based, real-world data repository covering >300 Million US patients, and linking >90 Million patients across claims and HER
  • Clients including 48 of the top 50 life sciences companies, 18 of the top 20 medical device companies, and 8 of the top 10 US payers and top US health systems
  • 96% client retention by value

`1,332 Crores


Healthcare Insights & Analytics - Addressable Market Size

($ Billions)

Healthcare services Life Sciences Provider Payer Total
Solution areas

Market Research

3.0 0.3 0.5 3.8

Consulting Services

2.7 0.6 0.8 4.1

Data & Analytics

4.5 2.4 1.5 8.4


10.2 3.3 2.8 16.3